<--- Back to Details
First PageDocument Content
Health / Medicine / Breakthrough therapy / Specialty drugs / Gilead Sciences / Healthcare-associated infections / Cyclopropanes / Sofosbuvir / Ledipasvir / National Institute for Health and Care Excellence / Hepatitis / National Health Service
Date: 2016-07-02 14:50:25
Health
Medicine
Breakthrough therapy
Specialty drugs
Gilead Sciences
Healthcare-associated infections
Cyclopropanes
Sofosbuvir
Ledipasvir
National Institute for Health and Care Excellence
Hepatitis
National Health Service

Microsoft Word - GILEAD BRIEFING

Add to Reading List

Source URL: www.ukts.org

Download Document from Source Website

File Size: 102,77 KB

Share Document on Facebook

Similar Documents

January 22, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Gilead Sciences, Galapagos Close $2 Billion Deal for Anti­Infla

DocID: 1rBxh - View Document

Gilead Sciences / Chemistry / HIV/AIDS / Medicine / Organofluorides / Specialty drugs / Prodrugs / Prevention of HIV/AIDS / AIDS Healthcare Foundation / Tenofovir alafenamide / Tenofovir disoproxil / Fixed-dose combination

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

DocID: 1rqYi - View Document

Business / Economy / Health care / Gilead Sciences / Specialty drugs / Pharmaceuticals policy / Tenofovir alafenamide / Valeant Pharmaceuticals / Tenofovir disoproxil / Rilpivirine / Pharmaceutical industry in China / AstraZeneca

March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

DocID: 1rdax - View Document

Health / Medicine / Breakthrough therapy / Specialty drugs / Gilead Sciences / Healthcare-associated infections / Cyclopropanes / Sofosbuvir / Ledipasvir / National Institute for Health and Care Excellence / Hepatitis / National Health Service

Microsoft Word - GILEAD BRIEFING

DocID: 1r2Vm - View Document

Medicine / Health / Gilead Sciences / Pre-exposure prophylaxis / Tenofovir/emtricitabine / Medical prescription / Emtricitabine / Tenofovir disoproxil / Health Insurance Portability and Accountability Act / Personal health record

Patient Name:________________________________________ Date of Birth:__________________ Truvada® for Pre-Exposure Prophylaxis (PrEP) Medication Assistance Program Page 1 of 4

DocID: 1qMRc - View Document